FTC Takes Sweeping Action Against Big Pharma’s Sham Patent Game, Ensuring Inhalers, EpiPens, and More Are Affordable and Accessible
November 7, 2023 — The Federal Trade Commission (FTC) announced new action today to challenge 100+ patents of brand name inhalers, epinephrine auto injectors and more — which follows the Commission’s passage of a policy statement condemning improper listing of patents in the Food and Drug Administration’s (FDA) Orange Book. In response, the American Economic Liberties Project released the following statement:
House Antitrust Leaders Bow to Monopolists with THUD Amendment Support
November 1, 2023 — As the House considers the Fiscal Year 2024 Transportation, Housing and Urban Development, and Related Agencies bill—an appropriations bill carrying a dangerous amendment, supported by House antitrust subcommittee chair Thomas Massie (R-KY) and ranking member Lou Correa (D-CA), to neuter the competition authorities of the Department of Transportation and other enforcers—the American Economic Liberties Project released the following statement:
Politico: The Next Generation of Law Students Is Obsessed With Lina Khan
November 6, 2023 — Economic Liberties' Anti-Monopoly Summit is highlighted in a feature on law students' excitement about strong antitrust enforcement.
Gizmodo: New Google Trial Docs May Explain Why Search Sucks So Bad Now
November 2, 2023 — Lee Hepner talks to Gizmodo about the latest findings in the Google search antitrust trial.
Amazon’s Own Executives Admit That Amazon Hurts Consumers and Inflates Prices, Updated FTC Complaint Reveals
November 2, 2023 — In response to a newly released version of the Federal Trade Commission’s complaint against Amazon, which makes public substantial previously-redacted information, the American Economic Liberties Project released the following statement.